Back
Innovent Biologics, Inc. 10K Form
Buy
57
IVBIY
Innovent Biologics, Inc.
Last Price:
$44.50
Seasonality Move:
6.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IVBIY News And Ratings
See the #1 stock for the next 7 days that we like better than IVBIY
IVBIY Financial Statistics
Sales & Book Value
| Annual Sales: | $1.8B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 134.51 |
| Annual Sales: | $4.41 |
| Price / Book: | 10.94 |
Profitability
| EPS (TTM): | 0.25730 |
|---|---|
| Net Income (TTM): | $112.1M |
| Gross Margin: | $1.6B |
| Return on Equity: | -0.75% |
| Return on Assets: | -0.46% |
Innovent Biologics, Inc. Earnings Forecast
Key Innovent Biologics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 10 years for IVBIY is 86.54%.
-
The Selling, General & Administrative Expenses for IVBIY have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 20.12% of Revenue.
-
The Interest Expense is 9.78% of Operating Income.
-
The Net Earning history of IVBIY is 6.24% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 6 years.
Innovent Biologics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Current Symbol: | IVBIY |
| Website: | innoventbio.com |
Debt
| Debt-to-Equity Ratio: | 0.21 |
|---|---|
| Current Ratio: | 2.35 |
| Quick Ratio: | 2.16 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IVBIY Technical Analysis vs Fundamental Analysis
Buy
57
Innovent Biologics, Inc. (IVBIY)
is a Buy
Is Innovent Biologics, Inc. a Buy or a Sell?
-
Innovent Biologics, Inc. stock is rated a BuyThe current Innovent Biologics, Inc. [IVBIY] share price is $44.50. The Score for IVBIY is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.